## 3 Results
\begin{table}
\begin{tabular}{c c c c c c c c} \hline \hline \multirow{2}{*}{**Time Points**} & \multicolumn{2}{c}{**MBM**} & \multicolumn{2}{c}{**Bone Loss**} & \multicolumn{2}{c}{**MBM**} & \multicolumn{2}{c}{**Bone Loss**} & \multicolumn{2}{c}{**MBM Test vs.**} \\  & **Control Group** & **Control Group** & **Test Group** & **Test Group** & **Test Group** & **\(\Delta\) & **Control** & **\(p\)-Value** \\  & **\(\Delta\) (CI 95\%)** & **\(\pm\)** & **\(\Delta\) (CI 95\%)** & \(\pm\)** & **(CI 95\%)** & \(\pm\)** & **(CI 95\%)** & \(\pm\)** \\ \hline T1–T0 & \(\begin{matrix}-0.44\\ (-0.67;\,-0.21)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.44\\ (-0.67;\,-0.21)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.65\\ (-0.89;\,-0.42)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.21\\ (-0.54;\,0.11)\end{matrix}\) & \(0.195\) \\ \hline T2–T0 & \(\begin{matrix}-0.49\\ (-0.72;\,-0.26)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.49\\ (-0.72;\,-0.26)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.72\\ (-0.95;\,-0.49)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.23\\ (-0.55;\,0.10)\end{matrix}\) & \(0.168\) \\ \hline T3–T0 & \(\begin{matrix}-0.52\\ (-0.75;\,-0.29)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.52\\ (-0.75;\,-0.29)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.60\\ (-0.83;\,-0.36)\end{matrix}\) & \(<\)0.01 & \(\begin{matrix}-0.07\\ (-0.40;\,0.25)\end{matrix}\) & \(0.657\) \\ \hline \hline \end{tabular}  
* Subcestal Implant. ** Bone Level Implant.  
\end{table} 
Table 4: Marginal Bone Modification (MBM), bone loss (BL) and bone remodeling at different time intervals. \begin{table}
\begin{tabular}{c c c c} \hline \hline \multirow{2}{*}{**Sites**} & \multicolumn{2}{c}{**Total**} & \multicolumn{2}{c}{**Control Group BLG**} & \multicolumn{2}{c}{**Test Group SCG**} \\  & **N (\%)** & **N (\%)** & **N (\%)** \\ \hline Implant & 3.6 \(\times\) 9: 23 (63.9\%) & 3.6 \(\times\) 9: 15 (83.3\%) & 3.6 \(\times\) 9: 8 (44.4\%) \\ (Diameter \(\times\) Length) & 4.3 \(\times\) 7:5: 13 (36.1\%) & 4.3 \(\times\) 7:5: 3 (16.7\%) & 4.3 \(\times\) 7:5: 10 (55.6\%) \\ \hline \multirow{4}{*}{Bone Density (Misch Classification)} & D1: 0 (0\%) & D1: 0 (0\%) & D1: 0 (0\%) \\  & D2: 4 (11\%) & D2: 3 (16.7\%) & D2: 1 (5.6\%) \\  & D3: 25 (69.4\%) & D3: 14 (77.8\%) & D3: 11 (61.1\%) \\  & D4: 7 (19.4\%) & D4: 1 (5.6\%) & D4: 6 (33.3\%) \\ \hline Healing Abutment (mm) & & 3.5: 6 (33.3\%) & \\ control group & & 4.5: 12 (66.7\%) & & \\ \hline GFA §(mm) & & & & 3.5: 7 (38.9\%) \\ test group & & & & 4.5: 9 (50\%) \\  & & & & 5.5: 2 (11.1\%) \\ \hline \hline \end{tabular}  
* Subcestal implant. ** Bone-level implant. § Negative values referred to apical MBM.  
\end{table} 
Table 3: _Cont._  
\begin{table}
\begin{tabular}{c c c c c c c c} \hline \hline \multirow{2}{*}{**Clinical Parameter**} & \multicolumn{2}{c}{**Control Group**} & \multicolumn{2}{c}{**Test Group**} & \multicolumn{2}{c}{**TEST vs. Control**} \\  & **6 Months** & **1 Year vs.**} & \multicolumn{2}{c}{**6 Months**} & \multicolumn{2}{c}{**1 Year vs.**} & \multicolumn{2}{c}{**6 Months**} & \multicolumn{2}{c}{**1 Year**} \\  & **6 Months** & **1 Year** & **6 Months** & **6 Months** & **1 Year** \\ \hline PPD (mm) & 3.18 & 3.04 & \( \begin{matrix}0.04\\ (-0.72;\,0.45)\end{matrix} \) & 2.33 & 2.38 & \( \begin{matrix}0.04\\ (-0.35;\,0.43)\end{matrix} \) & \( \begin{matrix}-0.85\\ (-1.136;\,-0.33)\end{matrix} \) & \( \begin{matrix}-0.67\\ (-1.14;\,-0.19)\end{matrix} \) \\  & **2.76** (3.60) & \( \begin{matrix}-0.67\\ (-0.67;\,-0.21)\end{matrix} \) & \( \begin{matrix}2.89\\ (-0.89;\,-0.42)\end{matrix} \) & \( \begin{matrix}2.83\\ (-0.89;\,-0.42)\end{matrix} \) & \( \begin{matrix}2.38\\ (-0.89;\,-0.42)\end{matrix} \) & \( \begin{matrix}2.38\\ (-1.35;\,-0.38)\end{matrix} \) & \(\begin{matrix}2.3